Description: CXLUSA is the world’s largest study group dedicated to less-invasive epithelium-on crosslinking (CXL), a keratoconus treatment in Phase 3 FDA clinical trials.
Health Conditions and Diseases Eye Disorders Cornea Keratoconus Treatment 网站
2024年11月16日